Ischaemic cardiac hyperaemia: Role of nitric oxide and other mediators

Physiological Research

Volumn 45, Issue 4, 1996, Pages 255-260

  Gryglewski, R J ^a   Chlopicki, S ^a   Niezabitowski, P ^a   Jakubowski, A ^a   Lomnicka, M ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

adenosine; cardiac ischaemia; cardiac reactive hyperaemia; endothelium; nitric oxide; prostacyclin

Indexed keywords

ADENOSINE; HYPOXANTHINE; INOSINE; PROSTACYCLIN; XANTHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART MUSCLE ISCHEMIA; HYPEREMIA; NONHUMAN; REGULATORY MECHANISM;

6-KETOPROSTAGLANDIN F1 ALPHA; ADENOSINE; ANIMALS; CORONARY CIRCULATION; CYCLIC GMP; CYCLOOXYGENASE INHIBITORS; ELECTROCARDIOGRAPHY; ENDOTHELINS; EPOPROSTENOL; GUINEA PIGS; HYPEREMIA; INDOMETHACIN; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PERFUSION; PROSTAGLANDIN ANTAGONISTS; PURINES; RECEPTORS, PURINERGIC P1; THEOPHYLLINE;

EID: 0029791674     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. AMEZCUA J.L., PALMER R.M., DE SOUZA B.M., MONCADA S.: Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br. J. Pharmacol. 97: 1119-1124, 1989.
2. BACHE R.J., COBB F.T., EBERT P.A., GREENFIELD J.C.: Neurogenic influences on the coronary vascular response to ischemia in the awake dog. J. Thorac. Cardiovasc. Surg. 69: 421-428, 1975.
3. BERNE R.M.: The role of adenosine in the regulation of coronary blood flow. Circ. Res. 47: 807-813, 1980.
4. BIERON K., GRODZINSKA L., KOSTKA-TRABKA E., GRYGLEWSKI R.J.: Prostacyclin and molsidomine synergise in their fibrinolytic and anti-platelet actions in patients with peripheral arterial disease. Wien. Klin. Wochenschr. 105: 7-11, 1993.
5. BORST M.M., SCHRADER J.: Adenine nucleotide release from isolated perfused guinea pig hearts and extracellular formation of adenosine. Circ. Res. 68: 797-806, 1991.
6. CHLOPICKI S., GRYGLEWSKI R.J.: Nitric oxide is a major mediator in reactive hyperaemia evoked by a brief coronary occlusion in the guinea pig heart. Eur. J. Pharmacol. 241: 117-120, 1993.
7. GRYGLEWSKI R.J., CHLOPICKI S., SWIES J., NIEZABITOWSKI P.: Prostacyclin, nitric oxide and atherosclerosis. In: Atherosclerosis III: Recent Advances in Atherosclerosis Research. F. NUMANO, R.W. WISSLER (eds), Ann. N. Y. Acad. Sci. 748: 194-207, 1995..
8. GRYGLEWSKI R.J., SWIES J.: Cardioprotection by molsidomine and iloprost in myocardial ischaemia in anaesthetized cats. Agent Actions Suppl. 37: 265-272, 1992.
9. HAYASHI Y., TOMOIKE H., NAGASAWA K., YAMADA A., NISHIJIMA H., ADACHI H., NAKAMURA M.: Functional and anatomical recovery of endothelium after denudation of coronary artery. Am. J. Physiol. 254: H1081-H1090, 1988.
10. HINTZE T.H., VATNER S.F.: Reactive dilatation of large coronary arteries in conscious dogs. Circ. Res. 54: 50-57, 1984.
11. KATZ L.N., LINDNER E.: Quantitative relationship between reactive hyperemia and the myocardial ischemia which it follows. Am. J. Physiol. 126: 283-288, 1939.
12. KOSTIC M.M., SCHRADER J.: Role of nitric oxide in reactive hyperemia of the guinea pig heart. Cir. Res. 70: 208-212, 1992.
13. KRAEMER R.J., PHERNETTON T.M., FOLTS J.D.: Prostaglandin-like substances in coronary venous blood following myocardial ischaemia. J. Pharmacol. Exp. Ther. 199: 611-619, 1976.
14. LAMONTAGNE D., POHL U., BUSSE R.: Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J. Cardiovasc. Pharmacol. 20: 652-657, 1992.
15. OLSSON R.A.: Myocardial reactive hyperemia. Circ. Res. 37: 263-270, 1975.
16. VANE J.R., BOTTING R.M.: Regulatory mechanisms of the vascular endothelium: an update. Pol. J. Pharmacol. 46: 499-521, 1994.
17. G-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release. J. Pharmacol. Exp. Ther. 257: 1208-1215, 1991.
18. WU X.B., BRÜNE B., VON APPEN F., ULLRICH V.: Efflux of cyclic GMP from activated human platelets. Mol. Pharmacol. 43: 564-568, 1993.